AI-powered Offensive Security Platform
Identify, assess, prioritize, and remediate cyber security vulnerabilities with agentic AI
Human-AI Teaming
Automated Reconnaisance
Continuously map your external attack surface to identify and enumerate all internet-facing services affiliated with your organization.
Complex Attack Simulations
AI-driven attack simulations and attack path analysis to identify, assess, and prioritize vulnerabilities.
Faster Remediation
AI-driven customized recommendations to improve vulnerability remediation time.
Why Specular?
Recent advancements in Large Language Models (LLMs) grant the ability to automate and heavily augment traditional human-driven vulnerability assessments. Our platform uses AI enable fast and accurate vulnerability identification, prioritization, and remediation at scale.
Our Mission
Building a Secure digital environment for our community and organizations in the private, public, and government sectors.
Meet Our Founders
Founder, CEO
Peyton is a software engineer turned cyber security specialist with experience in Red Teaming, Incident Response, and Threat Intelligence.
Before Specular, Peyton spent 5 years at CrowdStrike Services performing offensive operations and incident response for the Fortune 500. He has breached numerous enterprise networks and was a first responder to many of the most sophisticated nation-state and e-crime cyber intrusions in the world.
Prior to CrowdStrike, Peyton spent several years at Anomali (formerly ThreatStream) tracking Threat Actor activity by building OSINT and malware analysis pipelines.
Founder, CTO
Artem is an experienced software engineer and cloud architect who specializes in building robust backend systems and ML pipelines.
Previously, he was at Reddit, where he worked on core services that power the main feeds and was responsible for ranking, personalization, subreddit recommendations, and image search functionalities.
After Reddit, he worked at Lyell, where he led several projects to build data platform and cloud services, supporting research labs and a biomanufacturing facility.
Sign up for updates
We will never share your email address with third parties.